Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

12
Number of overlapping holdings
50.0%
% of PPH's 25 holdings also in XPH
29.3%
% of XPH's 41 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PPH |
Weight in XPH |
Overlap | |
---|---|---|---|---|
ZOETIS INC | 5.2% | 4.7% | 4.7% | |
MERCK & CO. INC. | 5.4% | 4.2% | 4.2% | |
ELI LILLY & CO | 5.2% | 4.0% | 4.0% | |
VIATRIS, INC. | 3.8% | 3.8% | 3.8% | |
JOHNSON & JOHNSON | 7.5% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XPH
NOVO-NORDISK A/S-SPONS ADR | 5.9% | |
ABBVIE INC | 5.6% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 5.3% | |
ASTRAZENECA PLC-SPONS ADR | 5.0% | |
SANOFI-AVENTIS-ADR | 4.7% | |
NOVARTIS AG-ADR | 4.7% | |
GLAXOSMITHKLINE PLC-SPON ADR | 4.4% | |
AMERISOURCEBERGEN CORP | 4.2% | |
MCKESSON CORP | 4.2% | |
JOHNSON & JOHNSON | 3.8% |
PPH Underweight Relative to XPH
REVANCE THERAPEUTICS INC | -6.0% | |
REATA PHARMACEUTICALS, INC. CLASS A | -5.5% | |
AXSOME THERAPEUTICS, INC. | -3.7% | |
ROYALTY PHARMA PLC CLASS A | -3.6% | |
PERRIGO CO | -3.4% | |
CATALENT INC | -3.4% | |
INTRA-CELLULAR THERAPIES INC | -3.0% | |
CASSAVA SCIENCES, INC. | -3.0% | |
AMYLYX PHARMACEUTICALS, INC. | -2.8% | |
PROVENTION BIO, INC. | -2.2% |